Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer
Clinical trial NCT00191568 · COMPLETED
Trial details
- NCT number
- NCT00191568
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.